Endocrine-Related Cancer or reduced-price access for institutions in certain developing countries to health-related research. The archive of published content from 1994 to 1997 is available to purchase by institutions as part of the Society for Endocrinology Archive. "Endocrine-Related Cancer" is abstracted and indexed in: Endocrine-Related Cancer Endocrine-Related Cancer is a monthly peer-reviewed medical journal covering cancers in endocrine organs — such as the breast, prostate, pituitary, testes, ovaries, and neuroendocrine system — and hormone-dependent cancers occurring elsewhere in the body. Its scope covers basic, translational, clinical and experimental studies. The journal is published by Bioscientifica on behalf of the Society for Endocrinology.
Multiple endocrine neoplasia type 2 are involved and selective resection of pathologic parathyroid glands for primary hyperparathyroidism. Familial genetic screening is recommended to identify at risk subjects who will develop the disease, permitting early management by performing prophylactic thyroidectomy, giving them the best chance of cure. Prognosis of MEN2 is mainly related to the stage-dependant prognosis of MTC indicating the necessity of a complete thyroid surgery for index cases with MTC and the early thyroidectomy for screened at risk subjects. Multiple endocrine neoplasia type 2 Multiple endocrine neoplasia type 2 (MEN2) (also known as "Pheochromocytoma and amyloid producing medullary thyroid carcinoma", "PTC syndrome," and "Sipple